COVID-19 drug discovery using intensive approaches (Int. J. Mol. Sci., 2020, in press).

COVID-19 drug discovery using intensive approaches (Int. J. Mol. Sci., 2020, in press).   

In the international collaboration with Hirotsu Bio Science Inc., Kinshu-kai Medical Corporation, IDEA Consultants Inc., Kyowa-kai Medical Corporation, Unitech Co. Ltd., as well as department of gastroenterology (Profs Yuichiro Doki and Hidetoshi Eguchi), Asai et al. reviewerd the state-of-art technology for the drug repositioning discovery against COVID-19. 

前へ ＜

＞ 次へ

記事一覧に戻る